{
    "clinical_study": {
        "@rank": "58866", 
        "arm_group": [
            {
                "arm_group_label": "Sepsis group", 
                "description": "Forty seven patients are critically ill with evidence of sepsis during ICU stay (sepsis group).  At admission, Patients data include clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum level of CD 14 and CD88   will be monitored."
            }, 
            {
                "arm_group_label": "SIRS group", 
                "description": "Forty seven  patients are critically ill without evidence of infectious organism (SIRS group).  At admission, Patients data include clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum level of CD 14 and CD88   will be monitored."
            }
        ], 
        "brief_summary": {
            "textblock": "The present study will be conducted to determine the dynamic changes of serum  soluble CD14\n       and the corresponding changes of serum CD88 and their correlation in critically ill sepsis\n      and SIRS patients."
        }, 
        "brief_title": "Serum CD14 and CD88 Mointoring in ICU", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": "Sepsis"
        }, 
        "detailed_description": {
            "textblock": "A total of ninty four will be included in the study. Forty seven patients are critically ill\n      with evidence of sepsis during ICU stay (sepsis group) and forty seven patients are\n      critically ill without evidence of infectious organism (SIRS group).  At admission, Patients\n      data include clinical status; SOFA score; central venous pressure; laboratory analysis and\n      arterial blood gas analysis are measured. Routine cultures will be obtained. The attending\n      physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as\n      their stay in ICU. A serum level of CD 14 and CD88   will be monitored."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patients staying in ICU for more than 24 hours will be included in the study.\n\n        Exclusion Criteria:\n\n          -  Patients received anti-inflammatory drugs or corticosteroids before admission,\n             patients had immunosuppressive illness, patients had chronic organ failure; patients\n             received massive blood transfusion; patients with radiation therapy and patients with\n             previous organ transplantation will be excluded from the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "A total of ninety-four patients will be included in the study. Forty seven patients are\n        critically ill with evidence of sepsis during ICU stay (sepsis group) and forty seven\n        patients are critically ill without evidence of infectious organism (SIRS group).  At\n        admission, Patients data include clinical status; SOFA score; central venous pressure;\n        laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be\n        obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or\n        septic shock as long as their stay in ICU. A serum level of CD 14 and CD88   will be\n        monitored."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02120534", 
            "org_study_id": "1638/02/13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "soluble CD14  ,serum CD88,sepsis , SIRS.", 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "contact": {
                "email": "ayman.yousef@rocketmail.com", 
                "last_name": "Ayman A Yousef, MD", 
                "phone": "00201003497767"
            }, 
            "facility": {
                "address": {
                    "city": "Tanta", 
                    "country": "Egypt", 
                    "state": "Algharbyia", 
                    "zip": "35217"
                }, 
                "name": "Tanta University Hospitals"
            }, 
            "investigator": {
                "last_name": "Ghada A Suliman, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Predictive Values of Serum Soluble CD14 Subtype and CD88 Monitoring in Critically Ill Patients.", 
        "overall_contact": {
            "email": "ayman.yousef@rocketmail.com", 
            "last_name": "Ayman A Yousef, MD", 
            "phone": "00201003497767"
        }, 
        "overall_contact_backup": {
            "email": "ayman.yousef@rocketmail.com", 
            "last_name": "Ayman A Yousef, MD"
        }, 
        "overall_official": {
            "affiliation": "Assistant Professor", 
            "last_name": "Ayman A Yousef, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At admission, Patients data include clinical status; SOFA score; central venous pressure; laboratory analysis and arterial blood gas analysis are measured. Routine cultures will be obtained. The attending physician will evaluate the patients for sepsis, severe sepsis, or septic shock as long as their stay in ICU. A serum level of CD 14   will be monitored.", 
            "measure": "A serum  soluble CD14", 
            "safety_issue": "Yes", 
            "time_frame": "one week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02120534"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tanta University", 
            "investigator_full_name": "Ayman Abd Al-maksoud Yousef", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Correlation of of serum  soluble CD14   and the corresponding changes of serum CD88 and their correlation in critically ill sepsis and SIRS patients and survival.", 
            "measure": "Survival of ICU patients", 
            "safety_issue": "Yes", 
            "time_frame": "Two weeks"
        }, 
        "source": "Tanta University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tanta University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}